| 1 min read
Register for free to listen to this article
Listen with Speechify
0:00
1:00
HARLOW, U.K.—CRO Argenta Discovery announced the signing of a lead-optimization collaboration with Finnish pharmaceutical company BioTie Therapies that will see the British company apply its expertise in medical chemistry, computational drug design, and early ADME to undisclosed BioTie therapeutic candidates. Financial terms of the deal were also not disclosed.
 
"Argenta has a good reputation in contract drug discovery, and we anticipate their skills and know-how will help accelerate this important 'first-in-class' late discovery programme into full pre-clinical development," says Dr Timo Veromaa, BioTie president and CEO.
 
The deal comes at a time when the European CRO market is in rapid expansion. According to a recent report by Frost & Sullivan, the market reached $4.8 billion in 2005 and should more than double to $10.21 billion by 2012. Said Frost analyst Dr. Amarpreet Dhiman: "Even as current pharmaceutical and biotechnology R&D spending levels surpass $36 billion and blockbuster drug development plateaus off, CROs are expanding in the direction of becoming either niche-specific or large service providers."

About the Author

Related Topics

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

GreenCooling

Thermo Scientific™ Centrifuges with GreenCool Technology

Next-generation natural refrigerant cooling system for centrifuges, offering a lower Global Warming Potential and reduced energy consumption.
Clear sample tubes are shown in a clear tote with red lids in a sample prep robot with a blue and silver industrial lab background.

The crucial role of sample preparation in biotherapy manufacturing

Discover how better sample preparation can unlock improved assay accuracy and analytical results.
A black mosquito is shown on pink human skin against a blurred green backdrop.

Discovering deeper insights into malaria research

Malaria continues to drive urgent research worldwide, with new therapies and tools emerging to combat the parasite’s complex lifecycle and global burden.
Drug Discovery News March 2025 Issue
Latest IssueVolume 21 • Issue 1 • March 2025

March 2025

March 2025 Issue

Explore this issue